Terapia com células-tronco: A Novel Approach for Early-Stage Chronic Kidney Disease
Doença renal crônica (DRC) is a global health concern, afetando milhões em todo o mundo. Current treatment options for CKD are limited, and most patients eventually progress to end-stage renal disease (DRT) requiring dialysis or transplantation. Terapia com células-tronco has emerged as a promising approach for treating early-stage CKD, offering the potential to repair damaged kidney tissue and restore function.
Exploring the Potential of Stem Cells in Kidney Repair
Stem cells are undifferentiated cells that have the ability to develop into various specialized cell types. No contexto da DRC, células-tronco podem ser derivadas de várias fontes, incluindo medula óssea, tecido adiposo, and the kidneys themselves. These stem cells can be directed to differentiate into functional kidney cells, como podócitos e células epiteliais tubulares, which are crucial for kidney function. By replacing damaged or lost kidney cells, stem cells can potentially restore kidney function and slow or halt the progression of CKD.
